HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
419.08
+4.19 (1.01%)
At close: Sep 26, 2025, 4:00 PM EDT
415.00
-4.08 (-0.97%)
After-hours: Sep 26, 2025, 7:46 PM EDT

HCA Healthcare Stock Forecast

Stock Price Forecast

The 14 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $408.79, which forecasts a -2.46% decrease in the stock price over the next year. The lowest target is $370 and the highest is $445.

Price Target: $408.79 (-2.46%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$370$408.79$410$445
Change-11.71%-2.46%-2.17%+6.18%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy444222
Buy666666
Hold676889
Sell100000
Strong Sell000000
Total171716161617

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$390$445
BuyMaintains$390$445+6.18%Sep 18, 2025
B of A Securities
B of A Securities
Hold
Maintains
$375$410
HoldMaintains$375$410-2.17%Sep 10, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$444
BuyReiterates$444+5.95%Aug 26, 2025
Baird
Baird
Hold
Maintains
$380$423
HoldMaintains$380$423+0.94%Aug 14, 2025
Wells Fargo
Wells Fargo
Hold
Maintains
$385$375
HoldMaintains$385$375-10.52%Aug 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
75.78B
from 70.60B
Increased by 7.33%
Revenue Next Year
79.09B
from 75.78B
Increased by 4.37%
EPS This Year
26.61
from 22.00
Increased by 20.96%
EPS Next Year
28.68
from 26.61
Increased by 7.79%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
51.53B58.75B60.23B64.97B70.60B75.78B79.09B
Revenue Growth
0.38%14.01%2.52%7.86%8.67%7.33%4.37%
EPS
10.9321.1619.1518.9722.0026.6128.68
EPS Growth
8.54%93.60%-9.50%-0.94%15.97%20.96%7.79%
Forward PE
-----15.7514.61
No. Analysts
-----2727
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High79.6B84.6B
Avg75.8B79.1B
Low73.0B74.3B

Revenue Growth

Revenue Growth20252026202720282029
High
12.7%
11.7%
Avg
7.3%
4.4%
Low
3.4%
-2.0%

EPS Forecast

EPS20252026202720282029
High28.2631.02
Avg26.6128.68
Low25.1225.92

EPS Growth

EPS Growth20252026202720282029
High
28.4%
16.6%
Avg
21.0%
7.8%
Low
14.2%
-2.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.